Matches in SemOpenAlex for { <https://semopenalex.org/work/W2538894230> ?p ?o ?g. }
- W2538894230 endingPage "1335" @default.
- W2538894230 startingPage "1326" @default.
- W2538894230 abstract "BackgroundThe causes of phenotypic heterogeneity in familial Alzheimer’s disease with autosomal dominant inheritance are not well understood. We aimed to characterise clinical phenotypes and genetic associations with APP and PSEN1 mutations in symptomatic autosomal dominant familial Alzheimer’s disease (ADAD).MethodsWe retrospectively analysed genotypic and phenotypic data (age at symptom onset, initial cognitive or behavioural symptoms, and presence of myoclonus, seizures, pyramidal signs, extrapyramidal signs, and cerebellar signs) from all individuals with ADAD due to APP or PSEN1 mutations seen at the Dementia Research Centre in London, UK. We examined the frequency of presenting symptoms and additional neurological features, investigated associations with age at symptom onset, APOE genotype, and mutation position, and explored phenotypic differences between APP and PSEN1 mutation carriers. The proportion of individuals presenting with various symptoms was analysed with descriptive statistics, stratified by mutation type.FindingsBetween July 1, 1987, and Oct 31, 2015, age at onset was recorded for 213 patients (168 with PSEN1 mutations and 45 with APP mutations), with detailed history and neurological examination findings available for 121 (85 with PSEN1 mutations and 36 with APP mutations). We identified 38 different PSEN1 mutations (four novel) and six APP mutations (one novel). Age at onset differed by mutation, with a younger onset for individuals with PSEN1 mutations than for those with APP mutations (mean age 43·6 years [SD 7·2] vs 50·4 years [SD 5·2], respectively, p<0·0001); within the PSEN1 group, 72% of age at onset variance was explained by the specific mutation. A cluster of five mutations with particularly early onset (mean age at onset <40 years) involving PSEN1’s first hydrophilic loop suggests critical functional importance of this region. 71 (84%) individuals with PSEN1 mutations and 35 (97%) with APP mutations presented with amnestic symptoms, making atypical cognitive presentations significantly more common in PSEN1 mutation carriers (n=14; p=0·037). Myoclonus and seizures were the most common additional neurological features; individuals with myoclonus (40 [47%] with PSEN1 mutations and 12 [33%] with APP mutations) were significantly more likely to develop seizures (p=0·001 for PSEN1; p=0·036 for APP), which affected around a quarter of the patients in each group (20 [24%] and nine [25%], respectively). A number of patients with PSEN1 mutations had pyramidal (21 [25%]), extrapyramidal (12 [14%]), or cerebellar (three [4%]) signs.InterpretationADAD phenotypes are heterogeneous, with both age at onset and clinical features being influenced by mutation position as well as causative gene. This highlights the importance of considering genetic testing in young patients with dementia and additional neurological features in order to appropriately diagnose and treat their symptoms, and of examining different mutation types separately in future research.FundingMedical Research Council and National Institute for Health Research." @default.
- W2538894230 created "2016-10-28" @default.
- W2538894230 creator A5001980450 @default.
- W2538894230 creator A5002376486 @default.
- W2538894230 creator A5009746896 @default.
- W2538894230 creator A5010587672 @default.
- W2538894230 creator A5018836358 @default.
- W2538894230 creator A5021772353 @default.
- W2538894230 creator A5023789263 @default.
- W2538894230 creator A5031717859 @default.
- W2538894230 creator A5032450718 @default.
- W2538894230 creator A5036742639 @default.
- W2538894230 creator A5050946548 @default.
- W2538894230 creator A5062072066 @default.
- W2538894230 creator A5065370594 @default.
- W2538894230 creator A5085975040 @default.
- W2538894230 creator A5086893120 @default.
- W2538894230 creator A5089535965 @default.
- W2538894230 date "2016-12-01" @default.
- W2538894230 modified "2023-10-17" @default.
- W2538894230 title "Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer’s disease: a case series" @default.
- W2538894230 cites W1260792146 @default.
- W2538894230 cites W1491165707 @default.
- W2538894230 cites W1570680710 @default.
- W2538894230 cites W1580355318 @default.
- W2538894230 cites W1890431460 @default.
- W2538894230 cites W1891797303 @default.
- W2538894230 cites W1928655587 @default.
- W2538894230 cites W1965252410 @default.
- W2538894230 cites W2006769360 @default.
- W2538894230 cites W2012635225 @default.
- W2538894230 cites W2029298729 @default.
- W2538894230 cites W2046209489 @default.
- W2538894230 cites W2056614031 @default.
- W2538894230 cites W2057591212 @default.
- W2538894230 cites W2058723245 @default.
- W2538894230 cites W2060807002 @default.
- W2538894230 cites W2072698534 @default.
- W2538894230 cites W2083633251 @default.
- W2538894230 cites W2087445172 @default.
- W2538894230 cites W2087744138 @default.
- W2538894230 cites W2093650784 @default.
- W2538894230 cites W2098476040 @default.
- W2538894230 cites W2107824265 @default.
- W2538894230 cites W2115361517 @default.
- W2538894230 cites W2119774197 @default.
- W2538894230 cites W2132680751 @default.
- W2538894230 cites W2134310798 @default.
- W2538894230 cites W2139238476 @default.
- W2538894230 cites W2141455952 @default.
- W2538894230 cites W2144021643 @default.
- W2538894230 cites W2146008734 @default.
- W2538894230 cites W2146729934 @default.
- W2538894230 cites W2147755473 @default.
- W2538894230 cites W2147778596 @default.
- W2538894230 cites W2163362744 @default.
- W2538894230 cites W2180506828 @default.
- W2538894230 cites W2281143377 @default.
- W2538894230 cites W943068505 @default.
- W2538894230 doi "https://doi.org/10.1016/s1474-4422(16)30193-4" @default.
- W2538894230 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27777022" @default.
- W2538894230 hasPublicationYear "2016" @default.
- W2538894230 type Work @default.
- W2538894230 sameAs 2538894230 @default.
- W2538894230 citedByCount "152" @default.
- W2538894230 countsByYear W25388942302012 @default.
- W2538894230 countsByYear W25388942302016 @default.
- W2538894230 countsByYear W25388942302017 @default.
- W2538894230 countsByYear W25388942302018 @default.
- W2538894230 countsByYear W25388942302019 @default.
- W2538894230 countsByYear W25388942302020 @default.
- W2538894230 countsByYear W25388942302021 @default.
- W2538894230 countsByYear W25388942302022 @default.
- W2538894230 countsByYear W25388942302023 @default.
- W2538894230 crossrefType "journal-article" @default.
- W2538894230 hasAuthorship W2538894230A5001980450 @default.
- W2538894230 hasAuthorship W2538894230A5002376486 @default.
- W2538894230 hasAuthorship W2538894230A5009746896 @default.
- W2538894230 hasAuthorship W2538894230A5010587672 @default.
- W2538894230 hasAuthorship W2538894230A5018836358 @default.
- W2538894230 hasAuthorship W2538894230A5021772353 @default.
- W2538894230 hasAuthorship W2538894230A5023789263 @default.
- W2538894230 hasAuthorship W2538894230A5031717859 @default.
- W2538894230 hasAuthorship W2538894230A5032450718 @default.
- W2538894230 hasAuthorship W2538894230A5036742639 @default.
- W2538894230 hasAuthorship W2538894230A5050946548 @default.
- W2538894230 hasAuthorship W2538894230A5062072066 @default.
- W2538894230 hasAuthorship W2538894230A5065370594 @default.
- W2538894230 hasAuthorship W2538894230A5085975040 @default.
- W2538894230 hasAuthorship W2538894230A5086893120 @default.
- W2538894230 hasAuthorship W2538894230A5089535965 @default.
- W2538894230 hasBestOaLocation W25388942301 @default.
- W2538894230 hasConcept C104317684 @default.
- W2538894230 hasConcept C118552586 @default.
- W2538894230 hasConcept C126322002 @default.
- W2538894230 hasConcept C175344181 @default.
- W2538894230 hasConcept C2776485563 @default.
- W2538894230 hasConcept C2776538686 @default.